DUBLIN, May 21, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/6csvbs/market_assessment) has announced the addition of the "Market Assessment of Respiratory Diagnostics in the United States and Europe" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This research service provides an analysis of the respiratory imaging diagnostics market in the United States and Europe. The service provides detailed analysis of the current and forecasted number of procedures, market size, and revenue forecast in respiratory diagnostics such as computed tomography, magnetic resonance imaging, positron emission tomography, x-ray, and spirometry. Market participants and key opinion leaders in the United States and Europe were interviewed to obtain perceptions of trends and opportunities in the respiratory diagnostics market. The study period is from 2011 to 2018, with 2013 as the base year. A CT scan is recommended for smokers over the age of (approximately million of the total million smokers), and million CT scans have been performed on people under the age of in the United States. The United States is the dominant region, with million lung-specific CT scans carried out every year; however, radiation exposure is a significant drawback of CT. Magnetic resonance imaging (MRI): Across geographies, the role of MRI for lung disease imaging is limited. Longer procedural time and a lack of precision to image a moving organ such as the lungs hamper the use of this type of imaging. Positron emission tomography (PET): This procedure is considered an alternative option for staging lung cancer, and it reduces radiation exposure when compared to CT. However, the high cost of equipment and the average cost of each scan is significantly high, which limits adoption in European countries as healthcare services are heavily subsidized. Healthcare service providers embrace radiation dose reduction technologies, reconstruction software, limited scan time, precise imaging of moving organs, and cost-effective products. The increasing incidences of lung disease across geographies provide a potential opportunity for technologies that satisfy the unmet needs in the current imaging modalities. Key Topics Covered: 1. Market Assessment of Respiratory Diagnostics in the United States and Europe 2. Executive Summary 3. Market Overview - Medical Imaging Industry 4. Clinical Workflow of Major Lung Disease Diagnosis in the United States 5. Lung Disease Incidences and Prevalence - Lung Conditions Requiring Medical Imaging Scans 6. Overall Medical Imaging Procedures by Country 7. Imaging Scans Market Size 8. Lung Imaging Market Breakdown by Geography 9. X-ray and Spirometry Market in the United States For more information visit http://www.researchandmarkets.com/research/6csvbs/market_assessment
Media Contact: Laura Wood , +353-1-481-1716, [email protected]
SOURCE Research and Markets
Advertisement
Research and Markets (http://www.researchandmarkets.com/research/6csvbs/market_assessment) has announced the addition of the "Market Assessment of Respiratory Diagnostics in the United States and Europe" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This research service provides an analysis of the respiratory imaging diagnostics market in the United States and Europe. The service provides detailed analysis of the current and forecasted number of procedures, market size, and revenue forecast in respiratory diagnostics such as computed tomography, magnetic resonance imaging, positron emission tomography, x-ray, and spirometry. Market participants and key opinion leaders in the United States and Europe were interviewed to obtain perceptions of trends and opportunities in the respiratory diagnostics market. The study period is from 2011 to 2018, with 2013 as the base year. A CT scan is recommended for smokers over the age of (approximately million of the total million smokers), and million CT scans have been performed on people under the age of in the United States. The United States is the dominant region, with million lung-specific CT scans carried out every year; however, radiation exposure is a significant drawback of CT. Magnetic resonance imaging (MRI): Across geographies, the role of MRI for lung disease imaging is limited. Longer procedural time and a lack of precision to image a moving organ such as the lungs hamper the use of this type of imaging. Positron emission tomography (PET): This procedure is considered an alternative option for staging lung cancer, and it reduces radiation exposure when compared to CT. However, the high cost of equipment and the average cost of each scan is significantly high, which limits adoption in European countries as healthcare services are heavily subsidized. Healthcare service providers embrace radiation dose reduction technologies, reconstruction software, limited scan time, precise imaging of moving organs, and cost-effective products. The increasing incidences of lung disease across geographies provide a potential opportunity for technologies that satisfy the unmet needs in the current imaging modalities. Key Topics Covered: 1. Market Assessment of Respiratory Diagnostics in the United States and Europe 2. Executive Summary 3. Market Overview - Medical Imaging Industry 4. Clinical Workflow of Major Lung Disease Diagnosis in the United States 5. Lung Disease Incidences and Prevalence - Lung Conditions Requiring Medical Imaging Scans 6. Overall Medical Imaging Procedures by Country 7. Imaging Scans Market Size 8. Lung Imaging Market Breakdown by Geography 9. X-ray and Spirometry Market in the United States For more information visit http://www.researchandmarkets.com/research/6csvbs/market_assessment
Media Contact: Laura Wood , +353-1-481-1716, [email protected]
SOURCE Research and Markets
